Menopause and Skin Health: Insights from Aspire Pharma and National Eczema Society

Research conducted by Aspire Pharma and National Eczema Society in October 2024, revealed the often-hidden impact of menopause on skin health, with many women encountering unexpected issues like dry skin and eczema as they undergo hormonal changes.   The…

Medicines Optimisation Centricity – Reimagining Value in the Patient Pathway

Executive Summary: Medicines Optimisation Centricity – Reimagining Value in the Patient Pathway Overview This white paper, developed by HSJ Advisory in partnership with Aspire Pharma, presents a compelling case for transforming medicines…

Reimagining Medicines Optimisation: A Call to Action for Addressing Health Inequalities

Petersfield, Hampshire, 30 October 2024 – Aspire Pharma Ltd in 2023 spearheaded an important initiative called Medicines Optimisation Centricity and initiated a White Paper published in May 2023 via Health Service Journal (HSJ), which urged…

Medicines Optimisation Centricity – addressing Access & Choice to Medicine Inequalities and Inequities

Petersfield, Hampshire, 01 October 2024, Aspire Pharma Ltd has initiated and funded a new report on improving access and choice to medicines by bringing the patient into the centre of the decision-making process; which follows the publication…

Medicines Optimisation Centricity – Getting It Right

Petersfield, Hampshire, 01 November 2023, Aspire Pharma Ltd initiated and funded the set-up of a series of round table events to discuss Medicines Optimisation Centricity. These events, facilitated by Wilmington Healthcare, as a data intelligence…